Description
Cancer treatment-related cardiotoxicity can occur due to direct effects on cardiac myocytes and may include damage to the vascular endothelium, hemodynamic flow alterations, and thrombotic events. Incidence of cardiotoxicity of cancer treatment vary from 7.4% to 13.3%. Leveraging an existing cohort, we identified a significant association between exposure to cardiotoxic chemotherapy and subsequent MI.
Learning Objective: Audiences will get new knowledge about how to extract cardiotoxic chemotherapy through knowledge bases and about association between exposure to cardiotoxic chemotherapy and subsequent MI.
Authors:
Liwei Wang (Presenter)
Mayo Clinic
Suzette J Bielinski, Mayo Clinic
Paul A. Decker, Mayo Clinic
Jill M. Killian, Mayo Clinic
Nicholas B. Larson, Mayo Clinic
Rui Zhang, University of Minnesota
Hongfang Liu, Mayo Clinic
Presentation Materials: